BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30628676)

  • 1. Effects of UPF1 expression on EMT process by targeting E‑cadherin, N‑cadherin, Vimentin and Twist in a hepatocellular carcinoma cell line.
    Li Y; Zhang T; Qin S; Wang R; Li Y; Zhou Z; Chen Y; Wu Q; Su F
    Mol Med Rep; 2019 Mar; 19(3):2137-2143. PubMed ID: 30628676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
    Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalpol inhibits the proliferation, migration and metastasis of HCC cells by regulating miR‑140‑5p expression.
    Wu L; Li H; Chen S; Wu X; Chen X; Wang F
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARK5 promotes doxorubicin resistance in hepatocellular carcinoma via epithelial-mesenchymal transition.
    Xu T; Zhang J; Chen W; Pan S; Zhi X; Wen L; Zhou Y; Chen BW; Qiu J; Zhang Y; Yang Q; Feng X; Bai X; Liang T
    Cancer Lett; 2016 Jul; 377(2):140-8. PubMed ID: 27126361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR7 preservation via histone deacetylase inhibition promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells.
    Yang L; Chang Y; Cao P
    Exp Cell Res; 2018 Oct; 371(1):231-237. PubMed ID: 30107147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
    Tanaka S; Shiraha H; Nakanishi Y; Nishina S; Matsubara M; Horiguchi S; Takaoka N; Iwamuro M; Kataoka J; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Nouso K; Yagi T; Yamamoto K
    Int J Cancer; 2012 Dec; 131(11):2537-46. PubMed ID: 22488108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
    Li Y; Chen G; Yan Y; Fan Q
    Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C/D box small nucleolar RNA SNORD52 regulated by Upf1 facilitates Hepatocarcinogenesis by stabilizing CDK1.
    Li C; Wu L; Liu P; Li K; Zhang Z; He Y; Liu Q; Jiang P; Yang Z; Liu Z; Yuan Y; Chang L
    Theranostics; 2020; 10(20):9348-9363. PubMed ID: 32802196
    [No Abstract]   [Full Text] [Related]  

  • 10. RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
    Song FN; Duan M; Liu LZ; Wang ZC; Shi JY; Yang LX; Zhou J; Fan J; Gao Q; Wang XY
    PLoS One; 2014; 9(9):e108507. PubMed ID: 25268581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang C; Guo F; Xu G; Ma J; Shao F
    Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZEB1 promotes tumorigenesis and metastasis in hepatocellular carcinoma by regulating the expression of vimentin.
    Qin Y; Yu J; Zhang M; Qin F; Lan X
    Mol Med Rep; 2019 Mar; 19(3):2297-2306. PubMed ID: 30664206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
    Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M
    Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. linc‑ROR facilitates hepatocellular carcinoma resistance to doxorubicin by regulating TWIST1‑mediated epithelial‑mesenchymal transition.
    Zhang Y; Wu W; Sun Q; Ye L; Zhou D; Wang W
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial‑mesenchymal transition.
    Yang G; Wang G; Xiong Y; Sun J; Li W; Tang T; Li J
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33907851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
    Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
    Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma.
    Meng J; Chen S; Han JX; Qian B; Wang XR; Zhong WL; Qin Y; Zhang H; Gao WF; Lei YY; Yang W; Yang L; Zhang C; Liu HJ; Liu YR; Zhou HG; Sun T; Yang C
    Cancer Res; 2018 Aug; 78(15):4150-4162. PubMed ID: 29844124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in microRNAs associated with Twist-1 and Bcl-2 overexpression identify signaling pathways.
    Zhao N; Sun BC; Zhao XL; Wang Y; Sun HZ; Dong XY; Meng J; Gu Q
    Exp Mol Pathol; 2015 Dec; 99(3):524-32. PubMed ID: 26341138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of ZEB2-AS1 decreased tumor growth and metastasis in hepatocellular carcinoma.
    Lan T; Chang L; Wu L; Yuan Y
    Mol Med Rep; 2016 Nov; 14(5):4606-4612. PubMed ID: 27748842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.
    Yang MH; Chen CL; Chau GY; Chiou SH; Su CW; Chou TY; Peng WL; Wu JC
    Hepatology; 2009 Nov; 50(5):1464-74. PubMed ID: 19821482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.